HDL - Cholesterol: The New Target for Treatment

Title: HDL - Cholesterol: The New Target for Treatment

Volume: 4 Issue: 2

Author(s): Sanjay Kalra, Bharti Kalra, Navneet Agrawal and Ashraf Ganie

Affiliation:

Keywords: HDL cholesterol, hyperlipidemia, niacin, fibrates, statins

Abstract: In spite of optimal treatment of LDL - cholesterol, as per evidence -based guidelines, only a one third reduction in cardiovascular risk is achieved in our patients. This has led to the realization that other types of cholesterol, too, need to be treated, in order to achieve ideal cardiovascular health. The review focuses on high density lipoprotein (HDL) cholesterol as a target for treatment, its importance, relevant patents and current as well as future treatments.

Cite this article as:

Kalra Sanjay, Kalra Bharti, Agrawal Navneet and Ganie Ashraf, HDL - Cholesterol: The New Target for Treatment, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2010; 4 (2) . https://dx.doi.org/10.2174/187221410791196605